Join in the fight against Covid/Flu Viruses
Are you eligible for our vaccine clinical research studies?
• No health insurance required
• Compensation for time and travel for qualified patients

Call Today!

IMA Clinical Research is seeking healthy adults for our
groundbreaking vaccine research studies.
We are hoping to find new and effective options to fight
against the Covid and Influenza viruses.


• Ages 18 – 64
• In Generally Good Health

Benefits of Participation

• Potentially discover new and effective treatment options
• Compensation provided for time and travel (for qualified
• No health insurance required
Together we can make a real difference in medical advancements. Join us on our journey toward improved immunity!
To learn more about our studies and how to participate:
Call us

ACHIEVE-4 is a clinical research study for people with type 2 diabetes and excess weight who are at risk for heart disease or stroke. The study will test how safe and well the investigational medicine (the medicine being studied) works for blood glucose and weight management compared with insulin therapy.

Can I join this study?

Yes, you may be able to join the research study if you:

  • Are aged 18 years or over
  • Have type 2 diabetes
  • Take at least 1 medicine to manage your diabetes
  • Have a BMI* of 25 or higher
  • Have or are at risk for heart disease, stroke, or other blood vessel diseases, or have kidney disease

*BMI stands for body mass index. If you do not know your BMI, please contact a healthcare professional.



Getting to the heart of cardiovascular disease

The VICTORION-2 PREVENT Study is testing an investigational drug to see whether it could help reduce the risk of future cardiovascular events, such as strokes and heart attacks, in people with cardiovascular disease (CVD).

If you are interested in taking part in the VICTORION-2 PREVENT Study, we’re searching for people who:

· Are 40 years of age and older

· Have previously experienced a heart attack, stroke or reduced blood flow to limbs caused by narrowed arteries (peripheral arterial disease)

· Are currently receiving a high-intensity statin (medication that lowers the level of harmful cholesterol in the blood)

There are other criteria that you will need to meet to qualify for participation in this study, which the study team can discuss with you.

For further information about the VICTORION-2 PREVENT Study, visit or contact:


Staying up to date on your COVID-19 vaccines is still the best way to protect yourself and others from serious illness. However, as the virus continues to change, vaccines must evolve as well. For this reason, we are looking for ways to make our current COVID-19 vaccine more effective against the newest variants.

Skip to content